Charles River Laboratories (CRL) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Charles River Laboratories Revenue Highlights


Latest Revenue (Y)

$4.13B

Latest Revenue (Q)

$1.03B

Main Segment (Y)

Service

Main Geography (Y)

UNITED STATES

Charles River Laboratories Revenue by Period


Charles River Laboratories Revenue by Year

DateRevenueChange
2023-12-30$4.13B3.86%
2022-12-31$3.98B12.31%
2021-12-25$3.54B21.08%
2020-12-26$2.92B11.55%
2019-12-28$2.62B15.67%
2018-12-29$2.27B21.99%
2017-12-30$1.86B10.48%
2016-12-31$1.68B23.34%
2015-12-26$1.36B5.06%
2014-12-27$1.30B11.34%
2013-12-28$1.17B3.19%
2012-12-29$1.13B-1.15%
2011-12-31$1.14B0.81%
2010-12-25$1.13B-5.75%
2009-12-26$1.20B-10.49%
2008-12-27$1.34B9.17%
2007-12-29$1.23B16.27%
2006-12-30$1.06B-5.69%
2005-12-31$1.12B46.33%
2004-12-25$766.92M24.96%
2003-12-27$613.72M10.65%
2002-12-28$554.63M19.11%
2001-12-29$465.63M51.88%
2000-12-31$306.58M39.82%
1999-12-25$219.28M13.44%
1998-12-31$193.30M-

Charles River Laboratories generated $4.13B in revenue during NA 2023, up 3.86% compared to the previous quarter, and up 182.23% compared to the same period a year ago.

Charles River Laboratories Revenue by Quarter

DateRevenueChange
2024-06-29$1.03B1.44%
2024-03-30$1.01B-0.19%
2023-12-30$1.01B-1.28%
2023-09-30$1.03B-3.14%
2023-07-01$1.06B2.97%
2023-04-01$1.03B-6.41%
2022-12-31$1.10B11.19%
2022-09-24$989.16M1.65%
2022-06-25$973.13M6.48%
2022-03-26$913.93M0.98%
2021-12-25$905.05M1.02%
2021-09-25$895.94M-2.04%
2021-06-26$914.61M10.92%
2021-03-27$824.57M4.24%
2020-12-26$790.99M6.42%
2020-09-26$743.30M8.90%
2020-06-27$682.58M-3.46%
2020-03-28$707.06M2.30%
2019-12-28$691.14M3.47%
2019-09-28$667.95M1.58%
2019-06-29$657.57M8.77%
2019-03-30$604.57M0.51%
2018-12-29$601.53M2.77%
2018-09-29$585.29M-0.00%
2018-06-30$585.30M18.49%
2018-03-31$493.97M3.24%
2017-12-30$478.48M3.07%
2017-09-30$464.23M-1.04%
2017-07-01$469.13M5.24%
2017-04-01$445.76M-4.50%
2016-12-31$466.79M9.65%
2016-09-24$425.72M-1.92%
2016-06-25$434.06M22.31%
2016-03-26$354.87M0.29%
2015-12-26$353.85M1.25%
2015-09-26$349.46M2.91%
2015-06-27$339.57M5.98%
2015-03-28$320.41M-2.77%
2014-12-27$329.55M0.60%
2014-09-27$327.57M-3.99%
2014-06-28$341.18M13.97%
2014-03-29$299.37M3.51%
2013-12-28$289.23M-0.99%
2013-09-28$292.13M-0.27%
2013-06-29$292.93M0.58%
2013-03-30$291.24M3.96%
2012-12-29$280.14M0.52%
2012-09-29$278.69M-2.12%
2012-06-30$284.72M-0.44%
2012-03-31$285.98M-1.71%
2011-12-31$290.96M4.82%
2011-09-24$277.58M-3.71%
2011-06-25$288.26M0.85%
2011-03-26$285.84M6.70%
2010-12-25$267.89M-2.97%
2010-09-25$276.08M-5.49%
2010-06-26$292.10M-1.76%
2010-03-27$297.35M0.66%
2009-12-26$295.38M-0.71%
2009-09-26$297.49M-3.46%
2009-06-27$308.16M2.20%
2009-03-28$301.53M-3.19%
2008-12-27$311.45M-8.99%
2008-09-27$342.23M-2.81%
2008-06-28$352.13M4.28%
2008-03-29$337.69M6.18%
2007-12-29$318.03M-

Charles River Laboratories generated $1.03B in revenue during Q2 2024, up 1.44% compared to the previous quarter, and up 99.68% compared to the same period a year ago.

Charles River Laboratories Revenue Breakdown


Charles River Laboratories Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Product$689.39M$759.16M$784.58M$627.78M$591.86M
Service$3.44B$3.22B$2.76B$2.30B$2.03B

Charles River Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 23: Service (83.31%), and Product (16.69%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jul 23Apr 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Manufacturing Support$196.88M$185.20M------------------
Discovery and Safety Assessment$615.06M$605.45M------------------
Product-$194.70M$175.47M$156.86M$185.05M$172.01M$199.15M$176.26M$190.30M$193.44M$195.23M$192.08M$199.29M$197.99M$172.76M$162.53M$132.02M$160.47M$141.76M$144.78M
Service-$816.86M$838.00M$869.76M$874.89M$857.37M$900.70M$812.89M$782.83M$720.49M$709.82M$703.86M$715.32M$626.58M$618.23M$580.77M$550.56M$546.59M$549.38M$523.17M

Charles River Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Discovery and Safety Assessment (75.75%), and Manufacturing Support (24.25%).

Charles River Laboratories Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
Other$16.85M$9.96M$7.29M$6.13M$5.50M
UNITED STATES$2.35B$2.34B$1.93B$1.63B$1.47B
Asia Pacific$200.83M$192.84M$222.90M--
CANADA$487.31M$398.98M$339.10M$306.26M$271.99M
Europe$1.08B$1.03B$1.04B$829.31M$726.42M
JAPAN---$155.09M$146.22M

Charles River Laboratories's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (56.85%), Europe (26.08%), CANADA (11.80%), Asia Pacific (4.86%), and Other (0.41%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Sep 23Jul 23Apr 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Europe$267.12M$276.32M$271.47M$264.79M$272.98M$267.70M$271.53M$245.93M$263.58M$251.09M$264.87M$258.35M$275.71M$237.53M$233.92M$214.19M$190.94M$190.26M$192.60M$184.69M
UNITED STATES$559.28M$562.32M$544.95M$590.32M$606.77M$605.44M$653.43M$595.26M$566.92M$526.55M$500.74M$493.56M$491.62M$448.48M$430.54M$406.98M$382.92M$406.71M$379.90M$373.09M
Asia Pacific$45.01M$45.77M$57.92M$40.23M$59.86M$42.81M$53.85M$43.80M$46.24M$48.95M$51.72M$56.61M$55.13M$59.45M$41.55M$35.97M$31.83M$36.70M--
CANADA$127.09M$110.40M$130.03M$129.02M$117.65M$110.61M$118.44M$101.60M$93.69M$85.25M$86.17M$85.25M$90.56M$77.11M$79.09M$79.00M$71.54M$76.63M$77.12M$71.98M
Other-$16.75M$9.10M$2.26M$2.67M$2.81M$2.60M$2.56M$2.70M$2.10M$1.55M$2.16M$1.58M$2.00M$1.70M$1.58M$1.22M$1.62M$1.38M$1.49M

Charles River Laboratories's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (56.01%), Europe (26.75%), CANADA (12.73%), and Asia Pacific (4.51%).

Charles River Laboratories Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
IQVIQVIA$14.98B$3.90B
LHLaboratory Corporation of America$12.16B$3.28B
ICLRICON Public Limited Company$8.12B$2.09B
AAgilent$6.83B$1.58B
ILMNIllumina$4.50B$1.08B
CRLCharles River Laboratories$4.13B$1.03B
MTDMettler-Toledo$3.79B$954.53M
IDXXIDEXX Laboratories$3.66B$975.54M
WATWaters$2.96B$740.30M
RVTYRevvity$2.75B$641.72M
MEDPMedpace$1.89B$533.32M
GHGuardant Health$563.95M$177.24M
CDNACareDx$280.32M$82.88M

CRL Revenue FAQ


What is Charles River Laboratories’s yearly revenue?

Charles River Laboratories's yearly revenue for 2023 was $4.13B, representing an increase of 3.86% compared to 2022. The company's yearly revenue for 2022 was $3.98B, representing an increase of 12.31% compared to 2021. CRL's yearly revenue for 2021 was $3.54B, representing an increase of 21.08% compared to 2020.

What is Charles River Laboratories’s quarterly revenue?

Charles River Laboratories's quarterly revenue for Q2 2024 was $1.03B, a 1.44% increase from the previous quarter (Q1 2024), and a -3.19% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.01B, a -0.19% decrease from the previous quarter (Q4 2023), and a -1.73% decrease year-over-year (Q1 2023). CRL's quarterly revenue for Q4 2023 was $1.01B, a -1.28% decrease from the previous quarter (Q3 2023), and a -7.85% decrease year-over-year (Q4 2022).

What is Charles River Laboratories’s revenue growth rate?

Charles River Laboratories's revenue growth rate for the last 3 years (2021-2023) was 16.64%, and for the last 5 years (2019-2023) was 57.54%.

What are Charles River Laboratories’s revenue streams?

Charles River Laboratories's revenue streams in c 23 are Product, and Service. Product generated $689.39M in revenue, accounting 16.69% of the company's total revenue, down -9.19% year-over-year. Service generated $3.44B in revenue, accounting 83.31% of the company's total revenue, up 6.94% year-over-year.

What is Charles River Laboratories’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Charles River Laboratories was Service. This segment made a revenue of $3.44B, representing 83.31% of the company's total revenue.